MEETINGS - Conference on the Delivery of Drugs by Inhalation (UK) February 2002:
This article was originally published in Clinica
Executive Summary
A conference on the Delivery of Drugs by Inhalation will be held on February 22 2002 at The Cafe Royal, London, UK. Topics include the latest scientific developments in aerosol and nasal spray drug delivery, the updated EMEA and FDA draft guidelines and the industries concerns and recommendations for future change. Further details from Henry Stewart Conference Studies on tel: +44 (0)20 7404 3040; fax: +44 (0)20 7404 2081; email: [email protected] www.henrystewart.co.uk
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.